Trial of Vaccine Therapy in Recurrent Platinum Sensitive Ovarian Cancer Patients

This study has been terminated.
(The study needed to be terminated due to new knowledge about cancer vaccines. A new protocol with an expected more efficient vaccine is currently being written.)
Sponsor:
Information provided by:
Oslo University Hospital
ClinicalTrials.gov Identifier:
NCT01334047
First received: March 30, 2011
Last updated: August 22, 2014
Last verified: August 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Estimated Study Completion Date: April 2022
  Primary Completion Date: August 2013 (Final data collection date for primary outcome measure)